Figshareopen access

<i>CYP2C19</i> genotype-guided P2Y12 inhibitor therapy optimization in patients at high bleeding risk: existing evidence and future directions

Name: CYP2C19 genotype-guided P2Y12 inhibitor therapy optimization in patients at high bleeding risk: existing evidence and future directions
License: Open Access

Ngoc Phuong Mai Le (24834004) et al.

Figshare · Datasets · License: Open Access

Open Source ↗

cancer genotype

medicine, cancer, information systems not elsewhere classified, antiplatelet therapy, cyp2c19, de-escalation, genotype, high bleeding risk

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 1015771
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.